Tags |
|
|
Links |
|
|
Digg It - In-sourcing a CRM System - Some Questions You Should Ask (Yourself).
If your company is taking the step to buy a third party CRM software it will face a lot of challenges. These challenges are not more or less when
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
you decide to make the software yourself. They are just different.
There are software vendors that provide a best-practice CRM-solution. And wh
There are software vendors that provide a best-practice CRM-solution. And wh
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
y should you not choose one of them? There are pro’s and con’s for each way you may decide. But if you decide to buy a CRM solution, this article
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
provides a additional vision on how to select the package. Additional and embracing other methods, because this approach is solving only a small
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
, yet important part.
In this approach you start at the top. You are not addressing the details, but you focus on the main characteristics of th
In this approach you start at the top. You are not addressing the details, but you focus on the main characteristics of th
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
e CRM package (which you match with your company profile).
When in-sourcing a “foreign” solution you might want to know about the origin of solu
When in-sourcing a “foreign” solution you might want to know about the origin of solu
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
tion. What is the architecture behind the solution and is it the same architectural approach of the suppliers that is made concrete in the packag
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
e? In that sense you are selecting the supplier more than the package.
The approach focuses on de similarities between the way you would solve a
The approach focuses on de similarities between the way you would solve a
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
CRM approach and the way the supplier did this for many other clients.
Different suppliers will have made different solutions according to thei
Different suppliers will have made different solutions according to thei
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
r preferences and style. This variation of approaches will result in different CRM solutions. To give some examples:
- Is the CRM solution
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
providing broad functionality for all range of companies or only for specific companies in specific sectors for in which it serves a profound fu
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
nctionality? (did the supplier want to serve the whole market or only a segment)
How open is the package. Does it easily integrate with
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
other solutions?
Is it providing a technical superior solution or is it focused on commercial practice?
What is the usabilit
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
y level of the system and how long is the learning curve?
How is the balance between innovation and conservation (is the system upwards
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
compatible)?
This last issue is important for you buy not only a package for not using your own resources today, but you also will
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
make yourself dependent on future developments. Can the supplier innovate as swiftly as you would yourself? And where does the supplier get is in
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
formation from? Does it innovate on basis of requirements that come from your company and others the have sold the package to, or do they have an
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
own line of strategy and expertise which they stick to? Especially when dealing with CRM you should observe the supplier in its Client approach.
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
When selecting a long-list or even a short-list you should focus on some main architectural characteristics of the solution you are to buy. And
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
check this with your own business profile. It is a simple (and reusable) step that saves you a lot of work in following stages.
© 2006 Hans Boo
© 2006 Hans Boo
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/23371/diggit-Insourcing-a-CRM-System--Some-Questions-You-Should-Ask-Yourself.html">In-sourcing a CRM System - Some Questions You Should Ask (Yourself).</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/23371/diggit-Insourcing-a-CRM-System--Some-Questions-You-Should-Ask-Yourself.html]In-sourcing a CRM System - Some Questions You Should Ask (Yourself).[/url]
Related Articles:
Making it Big as a Private Investigator in New Jersey
Creative And Innovative Thinking In Business: When And How Do You Think Creative Ideas?
Bookmark it:
|